Literature DB >> 16369747

Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection.

Takuhito Tada1, Haruyuki Fukuda, Katsuhiro Nakagawa, Kaoru Matsui, Masako Hosono, Yoshie Takada, Yuichi Inoue.   

Abstract

BACKGROUND: We investigated patterns of failure after radical radiation therapy in relation to the radiation field in patients with postsurgical locoregional recurrence of non-small cell lung cancer.
METHODS: Between 1992 and 2002, 31 patients with locoregional recurrence were treated with radiation therapy. At the time of radiation therapy, the sites of recurrence were the bronchial stump, the regional lymph nodes, the chest wall, and both the regional lymph nodes and the chest wall in 7, 20, 3, and 1 patient, respectively. The prescribed dose was 60 Gy in 30 fractions over 6 weeks in all patients.
RESULTS: The response rate was 87%. The overall 1-year, 2-year, and 4-year Kaplan-Meier survival rates were 61%, 30%, and 15%, respectively, and the median survival time was 14 months. Locoregional relapse with or without distant metastasis occurred in 15 patients (in-field, 7; marginal, 7; out-field, 1), and distant metastasis alone occurred in 7 patients. The sites of marginal relapse were the upper margin in two patients, the ipsilateral margin in one patient, the contralateral margin in one patient, and the lower margin in three patients, respectively (in one patient, the data for marginal relapse overlapped). In all patients with relapse on the lower margin, the mediastinal lymph nodes were dissected at the initial surgery.
CONCLUSION: Postoperative recurrent non-small cell lung cancer showed distinctive features: the response rate was high, and the incidence of marginal relapse was also high, as in small cell lung cancer. The incidence of lower marginal relapse was high, in contrast to that in surgery-naive patients.

Entities:  

Mesh:

Year:  2005        PMID: 16369747     DOI: 10.1007/s10147-005-0526-5

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.850


  14 in total

1.  External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection.

Authors:  B Jeremic; Y Shibamoto; B Milicic; S Milisavljevic; N Nikolic; A Dagovic; J Aleksandrovic; G Radosavljevic-Asic
Journal:  Lung Cancer       Date:  1999-02       Impact factor: 5.705

2.  Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.

Authors:  R Feld; L V Rubinstein; T H Weisenberger
Journal:  J Clin Oncol       Date:  1984-12       Impact factor: 44.544

3.  Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter.

Authors:  T Ishida; T Yano; K Maeda; S Kaneko; M Tateishi; K Sugimachi
Journal:  Ann Thorac Surg       Date:  1990-11       Impact factor: 4.330

4.  A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

Authors:  J D Cox; N Azarnia; R W Byhardt; K H Shin; B Emami; T F Pajak
Journal:  J Clin Oncol       Date:  1990-09       Impact factor: 44.544

5.  The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.

Authors:  L J Vanuytsel; J F Vansteenkiste; S G Stroobants; P R De Leyn; W De Wever; E K Verbeken; G G Gatti; D P Huyskens; G J Kutcher
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

6.  Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure.

Authors:  S C Immerman; R M Vanecko; W A Fry; L R Head; T W Shields
Journal:  Ann Thorac Surg       Date:  1981-07       Impact factor: 4.330

7.  Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.

Authors:  Ehab M Kamel; Daniel Zwahlen; Matthias T Wyss; Katrin D Stumpe; Gustav K von Schulthess; Hans C Steinert
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

8.  Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy.

Authors:  T Tada; K Minakuchi; M Koda; N Masuda; K Matsui; I Kawase; T Nakajima; M Nishioka; M Fukuoka; T Kozuka
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

9.  Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study.

Authors:  Hiroshi Onishi; Tsutomu Araki; Hiroki Shirato; Yasushi Nagata; Masahiro Hiraoka; Kotaro Gomi; Takashi Yamashita; Yuzuru Niibe; Katsuyuki Karasawa; Kazushige Hayakawa; Yoshihiro Takai; Tomoki Kimura; Yutaka Hirokawa; Atsuya Takeda; Atsushi Ouchi; Masato Hareyama; Masaki Kokubo; Ryusuke Hara; Jun Itami; Kazunari Yamada
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

10.  A single institutional subset analysis of the WJLCG study comparing concurrent and sequential chemoradiotherapy for stage III non-small-cell lung cancer.

Authors:  Takuhito Tada; Kazuo Minakuchi; Kaoru Matsui; Hideki Kin; Tomokazu Nishiguchi; Haruyuki Fukuda
Journal:  Radiat Med       Date:  2004 May-Jun
View more
  8 in total

1.  Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC.

Authors:  Paolo Borghetti; Jessica Imbrescia; Giulia Volpi; Vieri Scotti; Michele Aquilano; Alessio Bruni; Davide Franceschini; Stefano Ursino; Patrizia Ciammella; Gaia Piperno; Maria Taraborrelli; Stefano Maria Magrini
Journal:  Radiat Oncol       Date:  2022-07-16       Impact factor: 4.309

Review 2.  Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer.

Authors:  Tokujiro Yano; Tatsuro Okamoto; Seiichi Fukuyama; Yoshihiko Maehara
Journal:  World J Clin Oncol       Date:  2014-12-10

3.  Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy.

Authors:  Hong Seok Jang; Seong Kwon Moon
Journal:  Contemp Oncol (Pozn)       Date:  2015-01-12

4.  High dose involved field radiation therapy as salvage for loco-regional recurrence of non-small cell lung cancer.

Authors:  Sun Hyun Bae; Yong Chan Ahn; Heerim Nam; Hee Chul Park; Hong Ryull Pyo; Young Mog Shim; Jhingook Kim; Kwhanmien Kim; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

5.  Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells.

Authors:  Narumol Bhummaphan; Pithi Chanvorachote
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

6.  Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.

Authors:  Kakeru Hisakane; Kiyotaka Yoh; Naoki Nakamura; Hibiki Udagawa; Keisuke Kirita; Shigeki Umemura; Shingo Matsumoto; Seiji Niho; Tetsuo Akimoto; Masahiro Tsuboi; Koichi Goto
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

7.  Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer.

Authors:  Eunji Kim; Changhoon Song; Mi Young Kim; Jae-Sung Kim
Journal:  Radiat Oncol J       Date:  2017-02-13

8.  Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer.

Authors:  Kyung Hwa Lee; Yong Chan Ahn; Hongryull Pyo; Jae Myoung Noh; Seung Gyu Park; Tae Gyu Kim; Eonju Lee; Heerim Nam; Hyebin Lee; Jong-Mu Sun; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park
Journal:  Cancer Res Treat       Date:  2018-09-11       Impact factor: 4.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.